Loading clinical trials...
Loading clinical trials...
The trial is performed to assess efficacy and safety of Novo-Helisen Depot in allergic Rhinoconjunctivitis
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Allergopharma GmbH & Co. KG
NCT06920771 · House Dust Mite Allergy, House Dust Mite Rhinitis
NCT04874714 · Allergic Rhinoconjunctivitis, Perennial Allergic Rhinitis, and more
NCT05174689 · Exercise Induced Asthma, House Dust Mite Allergy
Allergopharma GmbH & Co. KG
Reinbek
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions